Literature DB >> 1325935

Correlation between hydrophobicity and resistance to nonoxynol-9 and vancomycin for urogenital isolates of lactobacilli.

L Tomeczek1, G Reid, P L Cuperus, J A McGroarty, H C van der Mei, A W Bruce, A E Khoury, H J Busscher.   

Abstract

Seven clinical isolates of lactobacilli were found to be relatively hydrophobic with a mean water-contact angle of 66 +/- 15 degrees, and to be susceptible to 1% nonoxynol-9 and vancomycin. However, seven other strains were relatively hydrophilic with a mean water-contact angle of 32 +/- 13 degrees, and found to be resistant to 25% nonoxynol-9 and vancomycin. Thus, the surface properties of lactobacilli that influence susceptibility to antimicrobial agents may involve surface hydrophobicity. Possibly the penetration barrier posed by the cell surface towards these two nonionic antimicrobials is lower for hydrophobic cells than for hydrophilic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325935     DOI: 10.1111/j.1574-6968.1992.tb05297.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  5 in total

Review 1.  The scientific basis for probiotic strains of Lactobacillus.

Authors:  G Reid
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

2.  Is There a Protective Role for Vaginal Flora?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Differentiation of Lactobacillus Species by Molecular Typing.

Authors: 
Journal:  Appl Environ Microbiol       Date:  1998-07-01       Impact factor: 4.792

4.  The cell wall of lactic acid bacteria: surface constituents and macromolecular conformations.

Authors:  Prisca Schär-Zammaretti; Job Ubbink
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

5.  Bacterial cell surface heterogeneity: a pathogen's disguise.

Authors:  Henny C van der Mei; Henk J Busscher
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.